$ cat ./records/gates-foundation-commits-100-million-to-unfpa-supplies-partnershi-2023.txt
Gates Foundation Commits $100 Million to UNFPA Supplies Partnership
[RECORD.TXT] · cat --full
The Gates Foundation made a long-term commitment of up to $100 million to the UNFPA Supplies Partnership, which procures and distributes contraceptives and maternal health commodities to 50-plus low-income countries. UNFPA Supplies is one of the world's largest purchasers of contraceptives, and Gates funding helps guarantee the supply of oral contraceptive pills, condoms, implants, and emergency obstetric supplies for governments that lack foreign currency to procure them independently. The commitment extended a relationship between Gates and UNFPA dating to an MOU signed in 2012.
Source: https://www.unfpa.org/updates/new-partnership-gates-foundation
Free forever · No ads · Solo developer
If this was worth a read, help make the next entry possible.
Every entry in this archive was researched, verified, and written by one person — for free. No corporate funding. No ad revenue. Just a developer who believes verified history should be accessible to everyone. Your donation directly funds new entries.
Crypto accepted · No subscription required
← Previous
Gates Foundation Expands Sayana Press Self-Injectable Contraceptive to 92 Countries
Next →
Gates Foundation Funds Quantoom Biosciences to Halve mRNA Vaccine Production Costs
[CROSS_REFERENCES] · grep --category='Global Health'
Related Accomplishments
January 2026
Gates-backed World Mosquito Program reaches 16 million people protected from dengue via Wolbachia method
The World Mosquito Program — backed in part by the Gates Foundation — announced in January 2026 that its Wolbachia-infected mosquito releases had reached over 16.1 million people across multiple countries, including Colombia, Indonesia, Brazil, Sri Lanka, Fiji, Vanuatu, and Vietnam. Wolbachia-carrying Aedes aegypti mosquitoes — which block dengue, Zika, chikungunya, and yellow fever transmission — had established self-sustaining populations in treated cities without requiring ongoing releases. Gold-standard randomised trials in Indonesia showed a 77% reduction in dengue incidence. The program represented one of the largest and most cost-effective vector control deployments in history.
2025
Gates-Funded Monoclonal Antibody Shows Early Promise as a Single-Shot Malaria Shield
[ARCHIVE_FUNDING] · INDEPENDENT · NO ADS
One developer. >300 verified entries. Zero ads. Forever free.
No sponsors, no paywall, no algorithm. If this archive has been useful to you, reader support is what keeps it running.